Corvus Pharmaceuticals, Inc. (CRVS)
NASDAQ: CRVS · Real-Time Price · USD
13.78
-0.14 (-1.01%)
Aug 5, 2026, 3:50 PM EDT - Market open
Corvus Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 | Jun '21 Jun 30, 2021 |
Net Income | -13.69 | -12.32 | -10.16 | -8 | 15.19 | -12.11 | -40.22 | -4.26 | -5.7 | -6.65 | -6 | -6.5 | -7.87 | -9.82 | -14.83 | -8.36 | -8.3 | -9.24 | -10.67 | -11.75 |
Depreciation & Amortization | 0.03 | 0.03 | 0.03 | 0.03 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.03 | 0.03 | 0.04 | 0.06 | 0.09 | 0.09 | 0.09 | 0.09 | 0.09 | 0.11 | 0.12 |
Stock-Based Compensation | 2.65 | 1.57 | 1.25 | 1.26 | 1.25 | 0.81 | 0.73 | 0.77 | 0.69 | 0.57 | 0.55 | 0.54 | 0.49 | 0.62 | 0.66 | 0.68 | 0.74 | 0.74 | 1.1 | 1.17 |
Other Adjustments | 0.58 | 0.45 | -0.14 | -1.96 | -24.88 | 4.28 | 33 | -1.46 | -0.39 | 1.28 | 0.62 | 1.03 | 1.47 | 4.46 | 2.65 | 1.64 | 1.1 | 2.59 | 1.75 | 0.54 |
Change in Receivables | -0.01 | -0.01 | 0.05 | -0.01 | -0 | -0.01 | -0.04 | -0.01 | - | -0.02 | -0.01 | 0.43 | 0.16 | -0.09 | -0.13 | 0 | 0.13 | -0.23 | -0.27 | -0 |
Changes in Accounts Payable | 2.21 | 0.52 | -1.16 | 1.83 | -1.27 | 0.71 | 0.66 | -0.4 | 0.08 | 0.12 | -0.69 | 0.69 | -0.57 | -2.25 | 1.83 | 0.21 | 0.62 | -0.77 | -0.53 | -2.05 |
Changes in Accrued Expenses | 0.5 | 0.77 | 0.71 | 1.14 | 0.15 | -0.49 | -0.09 | 0.23 | 0.1 | -0.59 | 0.1 | -1.16 | -1.93 | -1.02 | 2.2 | 0.39 | -1.1 | -0.88 | -0.39 | 0.45 |
Changes in Other Operating Activities | -2.64 | -0.19 | -0.15 | -0.07 | 1.28 | -1.67 | -0.4 | -0.37 | 0.03 | 0.09 | -0.02 | -0.28 | 0.08 | 0.48 | 0.62 | -0.76 | 0.29 | 0.83 | 0.49 | -1.13 |
Operating Cash Flow | -10.37 | -9.19 | -9.57 | -5.78 | -8.26 | -8.47 | -6.32 | -5.48 | -5.16 | -5.17 | -5.43 | -5.22 | -8.11 | -7.55 | -6.93 | -6.12 | -6.42 | -6.86 | -8.43 | -12.65 |
Operating Cash Flow Growth (YoY) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Capital Expenditures | -0.09 | -0.03 | 0 | -0.11 | -0.04 | - | - | - | - | 0 | 0 | 0 | -0.03 | 0 | -0.27 | -0 | - | -0.01 | 0 | - |
Purchases of Investments | -161.74 | -13.42 | -31.15 | -39.48 | -7.71 | -20.36 | -18.84 | -26.29 | -4.63 | -11.43 | -1.82 | -20.72 | -13.09 | -19.3 | -17.47 | -3.04 | -26.38 | -4.49 | -0.15 | -1.39 |
Proceeds from Sale of Investments | 16.98 | 24.32 | 28.53 | 19.29 | 11.99 | 14.27 | 14.95 | 8.79 | 4.62 | 9.11 | 19.36 | 16.43 | 17.73 | 15.4 | 20.78 | 6.18 | 0.81 | 2.5 | 3.63 | 16.63 |
Investing Cash Flow | -144.85 | 10.88 | -2.62 | -20.3 | 4.24 | -6.08 | -3.89 | -17.5 | -0.01 | -2.32 | 17.55 | -4.29 | 4.6 | -3.88 | 3.04 | 3.14 | -25.57 | -2 | 3.47 | 15.24 |
Issuance of Common Stock | 190.75 | 0.02 | 0.36 | 0.03 | 0.28 | 0.02 | 0.05 | - | - | 0 | 0.34 | 0 | 0 | - | - | - | - | 0.02 | 17.14 | 11.22 |
Net Common Stock Issued (Repurchased) | 190.75 | 0.02 | 0.36 | 0.03 | 0.28 | 0.02 | 0.05 | - | - | 0 | 0.34 | 0 | 0 | - | - | - | - | 0.02 | 17.14 | 11.22 |
Financing Cash Flow | 190.75 | 0.02 | 0.36 | 35.77 | 0.28 | 18.61 | 0.05 | 30.37 | - | 0 | 0.34 | 7.52 | 0 | - | - | - | - | 0.02 | 18.33 | 11.22 |
Net Cash Flow | 35.53 | 1.71 | -11.82 | 9.69 | -3.74 | 4.06 | -10.16 | 7.39 | -5.16 | -7.49 | 12.45 | -2 | -3.51 | -11.43 | -3.89 | -2.98 | -32 | -8.84 | 13.38 | 13.81 |
Free Cash Flow | -10.47 | -9.22 | -9.57 | -5.89 | -8.3 | -8.47 | -6.32 | -5.48 | -5.16 | -5.17 | -5.43 | -5.22 | -8.15 | -7.55 | -7.19 | -6.13 | -6.42 | -6.86 | -8.43 | -12.65 |
Free Cash Flow Growth (YoY) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Free Cash Flow Per Share | -0.12 | -0.11 | -0.12 | -0.08 | -0.11 | -0.12 | -0.09 | -0.09 | -0.11 | -0.11 | -0.11 | -0.11 | -0.17 | -0.16 | -0.15 | -0.13 | -0.14 | -0.15 | -0.19 | -0.30 |
Levered Free Cash Flow | -13.69 | -11.23 | -10.73 | -5.18 | 15.34 | -13.55 | -40.02 | -4.78 | -5.46 | -7 | -6.59 | -7.22 | -10.26 | -12.52 | -10.36 | -8.44 | -8.39 | -9.96 | -11 | -14.35 |
Unlevered Free Cash Flow | -14.88 | -11.13 | -11.15 | -7.44 | -9.78 | -9.54 | -7.06 | -6.45 | -6.01 | -6 | -6.15 | -6.33 | -8.96 | -8.37 | -8 | -7.09 | -7.51 | -7.53 | -9.37 | -13.89 |